There is a notable increase in thyroid cancer with the use of GLP-1R agonists, including semaglutide
Whether you are taking Ozempic or Wegovy, or using a compounded semaglutide option, the underlying mechanism remains the same
There are ups and downs, as well as adjustments, along the way
Scheede-Bergdahl C, Olsen DB, Reving D, Boushel R, Dela F
The 24.2% average weight loss seen with Retatrutide approaches the results typically achieved with bariatric surgery, which produces 25-30% weight loss
This is when practitioners typically decide whether to continue, adjust dose, or discontinue